Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


16.05.2022

1 Allergy
14 Arch Bronconeumol
6 Chest
2 Eur Respir J
5 J Allergy Clin Immunol
2 J Asthma
2 J Pediatr
1 N Engl J Med
2 PLoS One
3 Respir Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Allergy

  1. XING Y, Wang MH, Leung TF, Wong CK, et al
    Poultry exposure and environmental protection against asthma in rural children.
    Allergy. 2022 May 9. doi: 10.1111/all.15365.
    PubMed         Abstract available


    Arch Bronconeumol

  2. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
    [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
    Arch Bronconeumol. 2022;58:T334-T344.
    PubMed         Abstract available

  3. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
    Biological Biomarkers in Respiratory Diseases.
    Arch Bronconeumol. 2022;58:323-333.
    PubMed         Abstract available

  4. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
    [Translated article] Biological Biomarkers in Respiratory Diseases.
    Arch Bronconeumol. 2022;58:T323-T333.
    PubMed         Abstract available

  5. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
    [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
    Arch Bronconeumol. 2022;58:T345-T351.
    PubMed         Abstract available

  6. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
    The ANTES program in COPD: First year.
    Arch Bronconeumol. 2022;58:291-294.
    PubMed        

  7. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
    Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
    Arch Bronconeumol. 2022;58:345-351.
    PubMed         Abstract available

  8. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
    Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria with GOLD 2021?
    Arch Bronconeumol. 2022;58:364-366.
    PubMed        

  9. MACHUCA AGUADO J, Sabariego-Arenas I, Idoate MA
    A Pulmonary Inflammatory Chondroid Hamartoma With So-called Placental Transmogrification Feature in a Pleural Location. Pathogenic Considerations About This Unusual Disorder.
    Arch Bronconeumol. 2022;58:363.
    PubMed        

  10. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
    Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
    Arch Bronconeumol. 2022;58:334-344.
    PubMed         Abstract available

  11. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
    [Translated article] Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria With GOLD 2021?
    Arch Bronconeumol. 2022;58:T364-T366.
    PubMed        

  12. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
    [Translated article] The ANTES Program in COPD: First Year.
    Arch Bronconeumol. 2022;58:T291-T294.
    PubMed        

  13. CHINER-VIVES E, Cordovilla-Perez R, de la Rosa-Carrillo D, Garcia-Clemente M, et al
    Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.
    Arch Bronconeumol. 2022;58 Suppl 1:39-50.
    PubMed         Abstract available

  14. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
    [Translated article] Asthma Also Exists in Older People.
    Arch Bronconeumol. 2022 May 4. pii: S0300-2896(22)00312.
    PubMed        

  15. MARTINEZ-GONZALEZ C, Garcia JA, Blanco I
    [Translated article] Term Pregnancy in a Patient With Severe Pulmonary Emphysema Associated With Pi*ZZ Alpha-1 Antitrypsin Deficiency.
    Arch Bronconeumol. 2022 May 5. pii: S0300-2896(22)00311.
    PubMed        


    Chest

  16. IYER AS, Sullivan DR, Lindell KO, Reinke LF, et al
    The Role of Palliative Care in COPD.
    Chest. 2022;161:1250-1262.
    PubMed         Abstract available

  17. ESTHER CR JR, O'Neal WK, Anderson WH, Kesimer M, et al
    Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD.
    Chest. 2022;161:1239-1249.
    PubMed         Abstract available

  18. HULL RC, Huang JT, Barton AK, Keir HR, et al
    Sputum Proteomics in non-Tuberculous Mycobacterial Lung Disease.
    Chest. 2021 Nov 24. pii: S0012-3692(21)04412-3. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available

  19. LEE SY, Nyunt MSZ, Gao Q, Gwee X, et al
    Co-occurrence of Physical Frailty and COPD and Association With Disability and Mortality: Singapore Longitudinal Ageing Study.
    Chest. 2022;161:1225-1238.
    PubMed         Abstract available

  20. HUDLER AC, Sharma S
    Understanding the Genetics of Asthma-COPD Overlap.
    Chest. 2022;161:1125-1126.
    PubMed        

  21. SINGH J, Randev S, Kumar P, Mahajan V, et al
    A 16-Year-Old-Girl With Asthma, Palpable Purpura, and Hypereosinophilia.
    Chest. 2022;161:e305-e308.
    PubMed         Abstract available


    Eur Respir J

  22. KOEHLER P, von Stillfried S, Garcia Borrega J, Fuchs F, et al
    Aspergillus tracheobronchitis in COVID-19 patients with acute respiratory distress syndrome: a cohort study.
    Eur Respir J. 2022;59.
    PubMed        

  23. MATHIOUDAKIS AG, Abroug F, Agusti A, Ananth S, et al
    ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations.
    Eur Respir J. 2022;59.
    PubMed         Abstract available


    J Allergy Clin Immunol

  24. TAKESHITA J, Gupta J, Zhu Y, Berna R, et al
    Atopic dermatitis and the atopic march: considering racial and ethnic diversity in atopic disease progression.
    J Allergy Clin Immunol. 2022 Mar 19. pii: S0091-6749(22)00347.
    PubMed        

  25. BACHERT C, Sousa AR, Han JK, Schlosser RJ, et al
    Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count.
    J Allergy Clin Immunol. 2022;149:1711-1721.
    PubMed         Abstract available

  26. BAI Y, Guedes AGP, Krishnan R, Ai X, et al
    CD38 plays an age-related role in cholinergic deregulation of airway smooth muscle contractility.
    J Allergy Clin Immunol. 2022;149:1643-1654.
    PubMed         Abstract available

  27. BIAGINI JM, Kroner JW, Baatyrbek Kyzy A, Gonzales A, et al
    Longitudinal atopic dermatitis endotypes: An atopic march paradigm that includes Black children.
    J Allergy Clin Immunol. 2021 Oct 18. pii: S0091-6749(21)01555.
    PubMed         Abstract available

  28. HURRELL BP, Helou DG, Shafiei-Jahani P, Howard E, et al
    Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
    J Allergy Clin Immunol. 2022;149:1628-1642.
    PubMed         Abstract available


    J Asthma

  29. AGGARWAL S, Cepalo T, Gill S, Thipse M, et al
    Factors associated with future hospitalization among children with asthma: a systematic review.
    J Asthma. 2022 May 6:1-21. doi: 10.1080/02770903.2022.2070762.
    PubMed         Abstract available

  30. LEE S, Zhang A, Liu L, Salvo D, et al
    Changes in physical activity and sedentary time among children with asthma during the COVID-19 pandemic and influencing factors.
    J Asthma. 2022 May 9:1-9. doi: 10.1080/02770903.2022.2070761.
    PubMed         Abstract available


    J Pediatr

  31. SHEIN SL, Yehya N
    Trials and Tribulations in Bronchiolitis.
    J Pediatr. 2022;244:8-10.
    PubMed        

  32. GELBART B, McSharry B, Delzoppo C, Erickson S, et al
    Pragmatic Randomized Trial of Corticosteroids and Inhaled Epinephrine for Bronchiolitis in Children in Intensive Care.
    J Pediatr. 2022;244:17-23.
    PubMed         Abstract available


    N Engl J Med

  33. TRAVER EC, Gao NJ
    Emphysematous Aortitis.
    N Engl J Med. 2022;386:1833.
    PubMed        


    PLoS One

  34. KASO AW, Agero G, Hurissa Z, Kaso T, et al
    Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study.
    PLoS One. 2022;17:e0268280.
    PubMed         Abstract available

  35. FUTAMURA M, Hiramitsu Y, Kamioka N, Yamaguchi C, et al
    Prevalence of infantile wheezing and eczema in a metropolitan city in Japan: A complete census survey.
    PLoS One. 2022;17:e0268092.
    PubMed         Abstract available


    Respir Res

  36. LIU Y, Qu HQ, Qu J, Chang X, et al
    Burden of rare coding variants reveals genetic heterogeneity between obese and non-obese asthma patients in the African American population.
    Respir Res. 2022;23:116.
    PubMed         Abstract available

  37. GALGANI I, Annaratone M, Casula D, Di Maro G, et al
    Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study.
    Respir Res. 2022;23:114.
    PubMed         Abstract available

  38. KIM HS, An CH, Teller D, Moon SJ, et al
    The role of retinoid-related orphan receptor-alpha in cigarette smoke-induced autophagic response.
    Respir Res. 2022;23:110.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: